The hybrid capture II (HCII) ... The samples are classed as positive for HPV DNA if their RLU is over 1.0, which is equivalent to 1 pg of HPV DNA per ml. In conclusion, ...

High-risk HPV DNA is detected in more than 99% of cervical carcinoma worldwide. HPV testing can improve cervical cancer screening and has different applications: - As primary screening ...

Previous studies have demonstrated that ecDNA formed by the integration of HPV genes and human DNA is present in about 30% of HPV-positive oropharyngeal cancers.

The study shows how an HPV DNA test, which is cheaper than many current screening options, could make cervical cancer screening more accessible to women in countries with fewer resources.

Testing cervical specimens for DNA of oncogenic (high-risk) types of human papillomavirus (HPV), the causal agents of cervical cancer, has entered clinical practice, but this test is used mainly ...

According to a 2014 survey, some 9.4 percent of cervical cancers are unrelated to HPV, while 3.2 percent are caused by rare types of HPV that aren’t detected by the test.

Circulating tumor tissue-modified viral HPV DNA detected through a new assay appeared associated with nodal disease burden among patients with HPV-positive oropharyngeal squamous cell carcinoma ...

HealthDay News — A baseline negative human papillomavirus (HPV) DNA test provides greater reassurance against invasive cervical intraepithelial neoplasia grade 3 (CIN3) at 18-year follow-up than ...

HPV-positive circulating tumor (ct)DNA after chemoradiation (CRT) for cervical cancer had an independent association with worse outcomes, suggesting potential as a biomarker to guide decision ...